# reload+after+2024-01-20 12:35:46.472195
address1§7 Romans Business Park
address2§East Street
city§Farnham
zip§GU9 7SX
country§United Kingdom
phone§44 12 5272 8001
fax§44 12 5272 8002
website§https://www.bioventix.com
industry§Biotechnology
industryKey§biotechnology
industryDisp§Biotechnology
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, the United Kingdom.
fullTimeEmployees§12
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Peter John Harrison MA', 'age': 65, 'title': 'CEO & Director', 'yearBorn': 1958, 'fiscalYear': 2023, 'totalPay': 281633, 'exercisedValue': 0, 'unexercisedValue': 130100}, {'maxAge': 1, 'name': 'Mr. Bruce Edward Heath Hiscock', 'age': 65, 'title': 'CFO & Director', 'yearBorn': 1958, 'fiscalYear': 2023, 'totalPay': 95991, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§2
dividendRate§1.52
dividendYield§0.0347
exDividendDate§1699488000
payoutRatio§0.8592
fiveYearAvgDividendYield§2.62
beta§0.396
priceToSalesTrailing12Months§17.818048
currency§GBp
forwardEps§180.1
lastDividendValue§90.0
lastDividendDate§1699488000
exchange§LSE
quoteType§EQUITY
shortName§BIOVENTIX PLC ORD 5P
longName§Bioventix PLC
firstTradeDateEpochUtc§1398754800
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§3bce0cd0-5096-3a30-943d-df35acaa81a1
messageBoardId§finmb_23782495
targetHighPrice§4400.0
targetLowPrice§4400.0
targetMeanPrice§4400.0
targetMedianPrice§4400.0
recommendationKey§none
numberOfAnalystOpinions§1
quickRatio§5.74
earningsGrowth§-0.02
grossMargins§0.93536
ebitdaMargins§0.79581
trailingPegRatio§None
